A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC)
Clinical trial NCT05295927 · TERMINATED
Trial details
- NCT number
- NCT05295927
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-23
- Primary completion
- 2022-09-30
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.